Australia vs Cambodia: Treatment success rate for patients treated for MDR-TB
Australia
84.0%
in 2022
Cambodia
85.0%
in 2022
Australia rank
38th
Cambodia rank
35th
Treatment success rate for patients treated for MDR-TB over time
- Australia
- Cambodia
How they compare
Cambodia currently reports 85.0% against 84.0% in Australia, a difference of 1.0%.
The two have swapped places 5 times across 15 shared years of data; in 2008 it was Australia ahead.
Australia ranks 38th and Cambodia ranks 35th of 163 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.0% | 73.0% | 1.0% | Cambodia |
| 2010s | 73.4% | 75.4% | 2.0% | Cambodia |
| 2020s | 75.7% | 84.3% | 8.7% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Australia or Cambodia?
- Cambodia, at 85.0% against 84.0% in Australia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Australia and Cambodia?
- 1.0%, with Cambodia ahead.
- How many years of comparable data are there for Australia and Cambodia?
- 15 years are reported by both, from 2008 to 2022.
- How do Australia and Cambodia rank globally for treatment success rate for patients treated for mdr-tb?
- Australia ranks 38th and Cambodia ranks 35th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.